LifeTech Capital Recommends NovaBay Pharmaceuticals
NovaBay of Emeryville, Calif., develops antimicrobial products for a variety of infections, including conjunctivitis, MRSA, the skin disease impetigo, and urinary tract infections.
Month: January 2010
Sinus Patients May Benefit from Surgery, Study Finds
A new study by Oregon Health and Science University indicates that minimally invasive surgery can significantly benefit adults with chronic sinusitis.
Diabetes Drug Wins Approval, Helps the Competition
The approval of Novo Nordisk’s diabetes drug Victoza has led to an unintended benefit for a competitor.
ImmunoCellular Therapeutics at the 2010 OneMedForum
Manish Singh, President and CEO of ImmunoCellular Therapeutics, discusses his company with William Dawson of LifeTech Capital at the 2010 OneMedForum in San Francisco.
Sword Diagnostics at the 2010 OneMedForum
David Dingott, President and Founder of Sword Diagnostics, Inc., discusses his company with OneMedTV correspondent Alicia Ontiveros at the 2010 OneMedForum in San Francisco.
Cleveland BioLabs at the 2010 OneMedForum
Michael Fonstein, President and CEO of Cleveland BioLabs, discusses his company with William Dawson of LifeTech Capital at the 2010 OneMedForum in San Francisco.
Facet Solutions at the 2010 OneMedForum
Geoff Pardo, President and CEO of Facet Solutions, discusses his company with OneMedTV correspondent Alicia Ontiveros at the 2010 OneMedForum conference.
Immunomic Therapeutics at the 2010 OneMedForum
Dr. William G. Hearl, CEO of Immunomic Therapeutics, discusses his company with OneMedTV correspondent Alicia Ontiveros at the 2010 OneMedForum in San Francisco.
Clarient, Inc. at the 2010 OneMedForum
Ron Andrews, CEO of Clarient, Inc., discusses his company with William Dawson of LifeTech Capital at the 2010 OneMedForum in San Francisco.
Strategic Medicine at the 2010 OneMedForum
Michael N. Liebman, President and Managing Director of Strategic Medicine, discusses his company with OneMedTV correspondent Alicia Ontiveros at the 2010 OneMedForum in San Francisco.